Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Northeastern University Joins CIMIT Consortium

Published: Friday, December 03, 2010
Last Updated: Friday, December 03, 2010
Bookmark and Share
Adds strengths in healthcare systems engineering, nanotechnology and use-inspired research.

Northeastern University has joined the Center for Integration of Medicine and Innovative Technology (CIMIT), a pioneering consortium  of teaching hospitals, research laboratories, and engineering schools in the Boston area. Northeastern’s excellence in use-inspired research across multiple areas of scientific discovery will advance the consortium’s mission to make a profound impact on grand challenges in health care through engineering solutions.

“The greatest innovations are born from the collaboration of scientific discovery, technological breakthrough and commercial implementation,” said Northeastern University President Joseph E. Aoun, who is joining CIMIT’s executive committee. “Northeastern’s ambitious research portfolio in areas of health, nanotechnology and engineering will be critical to the success of the innovations created by this partnership.”

Tapping into Northeastern’s interdisciplinary research strengths, including nanomedicine, sensing and imaging, neuroinformatics, healthcare systems engineering, and robotics, the collaboration builds upon the University’s research priorities that lead to breakthroughs in health, security and sustainability. Most recently, Northeastern has been designated as a Center of Cancer Nanotechnology Excellence by the National Cancer Institute.

CIMIT acts as an infrastructure to enable inter-institutional collaboration between scientists, engineers and clinicians, and helps fund early-stage, high-risk ideas in the first phase of innovation. Through this membership, Northeastern will build upon its robust network of existing clinical partnerships by forging new collaborations in translational research. In addition, the partnership will present new opportunities for undergraduate and graduate students in areas such as co-op, research, and the capstone program.

“Northeastern University brings additional excellence in biomedical engineering into the consortium,” said John A. Parrish, M.D., executive director and chief executive officer of CIMIT. “This opportunity to collaborate more closely with research faculty at Northeastern offers additional state-of-the-art technology and engineering research resources for clinically-based innovators in the Boston area. In the years ahead, we look forward to working with many Northeastern scientists and engineers as we pursue our shared goal of finding novel solutions to improve patient care.”

Northeastern joins CIMIT’s other consortium members: Beth Israel Deaconess Medical Center, Boston Medical Center, Boston University, Brigham and Women’s Hospital, Children’s Hospital Boston, Charles Stark Draper Laboratory, Harvard Medical School, Massachusetts General Hospital, Massachusetts Institute of Technology, Newton-Wellesley Hospital, Partners HealthCare, and VA Boston Healthcare System.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Northeastern University Receives $1.2m from the W.M. Keck Foundation to Develop Nanodevices
The University will use the two year grant to develop the nanochip’s major design features for biomarker monitoring and controlled drug release.
Friday, February 02, 2007
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
Parsortix Demonstrates Benefits Over Marker-Based Systems
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumour cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis.
Experimental Therapy For Brain Cancer Could Prevent Drug Resistance
Information from penny-sized microfluidic chips allowed researchers to anticipate resistance to cancer treatment.
3D Printing of Lego Fluidics
Study shows how 3D printing can open up microfluidic technology to a wider audience.
New Method to Preserve Device to Monitor HIV Treatment
Inspired by pregnancy tests, scientists have developed a method to store microfluidic devices for months without refrigeration, giving developing countries an inexpensive and reliable way to treat patients.
Migration Creates Cancer Cell Vulnerabilities
Scientists found that migration can damage cancer cells’ nuclei and DNA, requiring repairs for their survival. The results may open new avenues for targeting metastatic cancer.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!